Induction of cell-mediated IL-2-activated antitumor responses in conjunction with autologous and allogeneic bone marrow transplantation.
Slavin
S
S
Department of Bone Marrow Transplantation, Hadassah-Hebrew University Hospital and School of Medicine, Jerusalem, Israel.
Ackerstein
A
A
Kedar
E
E
Reich
S
S
Gomez
S
S
Naparstek
E
E
Nagler
A
A
Or
R
R
Weiss
L
L
D000818:Animals; D016026:Bone Marrow Transplantation; D003131:Combined Modality Therapy; D007376:Interleukin-2 / Q000627:therapeutic use*; D007942:Leukemia, Experimental / Q000628:therapy*; D051379:Mice; D008807:Mice, Inbred BALB C; D008815:Mice, Inbred Strains; D011994:Recombinant Proteins / Q000627:therapeutic use; D014182:Transplantation, Autologous; D014184:Transplantation, Homologous
D007376:Interleukin-2; D011994:Recombinant Proteins